MAP3K7CL antibody (C-Term)
Quick Overview for MAP3K7CL antibody (C-Term) (ABIN629829)
Target
See all MAP3K7CL AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- C21 ORF7 antibody was raised against the C terminal Of C21 rf7
-
Purification
- Purified
-
Immunogen
- C21 ORF7 antibody was raised using the C terminal Of C21 rf7 corresponding to a region with amino acids DSEESMEVFKQHCQIAEEYHEVKKEITLLEQRKKELIAKLDQAEKEKVDA
-
-
-
-
Application Notes
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
C21ORF7 Blocking Peptide, (ABIN937547), is also available for use as a blocking control in assays to test for specificity of this C21ORF7 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of C20 RF7 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- MAP3K7CL (MAP3K7 C-Terminal Like (MAP3K7CL))
-
Alternative Name
- C21ORF7
-
Background
- C21orf7 plays a critical role in the TGF-beta signaling transduction pathway.
-
Molecular Weight
- 27 kDa (MW of target protein)
Target
-